Guardant Health, Inc. Common Stock
GH · Medical Laboratories · $24.1B
Powering up
Not on a screen at the moment — no base, so no pivot to draw. The price and volume are below.
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
The read
Guardant Health, Inc. Common Stock is not on any of the screens right now. Its relative strength rating is 97, and it sits in Medical Laboratories.
Peers
Catalyst roadmap
Nothing dated in the next three months that we can ingest automatically.
Flagged by the market sweep
GappedTape · 2026-09-15
+6.6%
From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.
In the news
AstraZeneca Secures FDA Nod for New Breast Cancer Therapy EtcamahZacks Investment Research · 12 days ago
Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.
Insiders
No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.
X-ray